Supha Pharmachem Ltd logo

Supha Pharmachem Ltd (SUPHA) share fundamentals

MaterialsSpecialty Chemicalsmicro-capNSE / BSE

Supha Pharmachem Ltd is a micro-cap company in Materials (Specialty Chemicals) with a market capitalisation of ₹23 crore. Here is where it stands on valuation, profitability, debt and growth as of 5 November 2026, and how it compares with the median Materials company.

Share price₹0.27
Market cap₹23 crore
PE ratio10.77x
ROCE27.4%
Debt / equity26.01x
1-year return-82.7%

Financial health score

42.1
Caution

Out of 100, across five pillars of reported fundamentals.

Profitability52
Debt & solvency8
Valuation67
Growth—
Governance50

What stands out

Supha Pharmachem Ltd vs the Materials median

MetricSUPHASector median
PE ratioprice paid for each rupee of yearly profit10.77x16.71xBetter
Price to bookprice against the book value of assets0.52x1.55xBetter
EV / EBITDAbusiness value against operating profit96.43x10.89xWeaker
Dividend yieldyearly dividend as a share of price—0.7%
Return on equityprofit on shareholders’ money—8.4%
ROCEprofit on all capital employed27.4%11.1%Better
Net profit marginprofit kept from each rupee of sales0.5%4.1%Weaker
Debt to equityborrowing against shareholders’ money26.01x0.32xWeaker
Interest coveragehow many times profit covers interest1.57x4.18xWeaker
Current ratioshort-term assets against short-term dues1.03x1.7xWeaker
Revenue growth (1Y)change in sales over a year—9.5%
EPS growth (1Y)change in earnings per share over a year—9.2%
Promoter holdingshare owned by the founders or parent1.1%62.2%Weaker
Promoter pledgepromoter shares pledged as loan security0%0%In line
Betahow much it moves with the market1.891.05
1-year returnshare price change over 52 weeks-82.7%-11.6%
Want a plan built around your money?

Tell DecideChart your amount, timeline and target return, and AI builds a full A4 report with risks, scenarios and worst cases. Your first report is free.

Decide · where to investOpen on the chart

Other Materials companies

See all Materials stocks →

Frequently asked questions

What is the PE ratio of Supha Pharmachem Ltd?

Supha Pharmachem Ltd trades at a PE of 10.77x as of 5 November 2026, against a Materials median of 16.71x. PE is the price paid for each rupee of yearly profit.

Is Supha Pharmachem Ltd debt free?

No. Supha Pharmachem Ltd has a debt-to-equity ratio of 26.01x, against a Materials median of 0.32x.

What is the ROCE and ROE of Supha Pharmachem Ltd?

Supha Pharmachem Ltd has a return on capital employed of 27.4% and a return on equity of —. The Materials medians are 11.1% and 8.4%.

What is the DecideChart health score of Supha Pharmachem Ltd?

Supha Pharmachem Ltd scores 42.1 out of 100, graded Caution. The score weighs profitability, debt, valuation, growth and governance from the company’s reported numbers. It is a research aid, not a recommendation.

Should I buy Supha Pharmachem Ltd shares?

DecideChart does not give buy or sell tips and is not linked to SEBI, BSE or NSE. Use these numbers for your own research, compare Supha Pharmachem Ltd with its Materials peers, and consult a SEBI-registered adviser before investing.

Fundamentals from a public market-data screener, as of 5 November 2026. Figures can lag company filings. DecideChart is AI-based, not linked to SEBI, BSE or NSE, and does not give investment advice.